Visvikis D - Search Results

1

In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography.

Francis DL, Freeman A, Visvikis D, Costa DC, Luthra SK, Novelli M, Taylor I, Ell PJ. Francis DL, et al. Among authors: visvikis d. Gut. 2003 Nov;52(11):1602-6. doi: 10.1136/gut.52.11.1602. Gut. 2003. PMID: 14570730 Free PMC article.

2

Positron emission tomography and colorectal cancer.

Arulampalam TH, Costa DC, Loizidou M, Visvikis D, Ell PJ, Taylor I. Arulampalam TH, et al. Among authors: visvikis d. Br J Surg. 2001 Feb;88(2):176-89. doi: 10.1046/j.1365-2168.2001.01657.x. Br J Surg. 2001. PMID: 11167864 Review.

3

Functional imaging of malignant paragangliomas and carcinoid tumours.

Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ. Le Rest C, et al. Among authors: visvikis d. Eur J Nucl Med. 2001 Apr;28(4):478-82. doi: 10.1007/s002590100475. Eur J Nucl Med. 2001. PMID: 11357498

4

The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.

Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P. Arulampalam T, et al. Among authors: visvikis d. Eur J Nucl Med. 2001 Dec;28(12):1758-65. doi: 10.1007/s002590100646. Epub 2001 Oct 20. Eur J Nucl Med. 2001. PMID: 11734912

5

Glucose utilisation and cell proliferation in colorectal cancer.

Visvikis D, Francis DL, Costa DC, Mulligan R, Townsend C, Arulampalam TH, Islam MS, Taylor I, Ell PJ. Visvikis D, et al. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):280. doi: 10.1007/s00259-001-0754-5. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926392 No abstract available.

6

Positron emission and computed X-ray tomography: a coming together.

Costa DC, Visvikis D, Crosdale I, Pigden I, Townsend C, Bomanji J, Prvulovich E, Lonn A, Ell PJ. Costa DC, et al. Among authors: visvikis d. Nucl Med Commun. 2003 Apr;24(4):351-8. doi: 10.1097/00006231-200304000-00003. Nucl Med Commun. 2003. PMID: 12673162

7

Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.

Francis DL, Visvikis D, Costa DC, Arulampalam TH, Townsend C, Luthra SK, Taylor I, Ell PJ. Francis DL, et al. Among authors: visvikis d. Eur J Nucl Med Mol Imaging. 2003 Jul;30(7):988-94. doi: 10.1007/s00259-003-1187-0. Epub 2003 May 9. Eur J Nucl Med Mol Imaging. 2003. PMID: 12739071 Clinical Trial.

8

Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.

Visvikis D, Ell PJ. Visvikis D, et al. Eur J Nucl Med Mol Imaging. 2003 Jun;30 Suppl 1:S106-16. doi: 10.1007/s00259-003-1168-3. Epub 2003 May 13. Eur J Nucl Med Mol Imaging. 2003. PMID: 12748830 Review.

9

Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.

Francis DL, Visvikis D, Costa DC, Croasdale I, Arulampalam TH, Luthra SK, Taylor I, Ell PJ. Francis DL, et al. Among authors: visvikis d. Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):928. doi: 10.1007/s00259-003-1438-0. Epub 2004 Mar 18. Eur J Nucl Med Mol Imaging. 2004. PMID: 15034675 No abstract available.

10

Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.

Visvikis D, Francis D, Mulligan R, Costa DC, Croasdale I, Luthra SK, Taylor I, Ell PJ. Visvikis D, et al. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):169-78. doi: 10.1007/s00259-003-1339-2. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129698 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page